241 related articles for article (PubMed ID: 35068797)
1. Magnetic Resonance Elastography for the Clinical Risk Assessment of Fibrosis, Cirrhosis, and Portal Hypertension in Patients With NAFLD.
Natarajan Y; Loomba R
J Clin Exp Hepatol; 2022; 12(1):174-179. PubMed ID: 35068797
[TBL] [Abstract][Full Text] [Related]
2. Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Imajo K; Honda Y; Kobayashi T; Nagai K; Ozaki A; Iwaki M; Kessoku T; Ogawa Y; Takahashi H; Saigusa Y; Yoneda M; Kirikoshi H; Utsunomiya D; Aishima S; Saito S; Nakajima A
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):908-917.e11. PubMed ID: 33340780
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.
Selvaraj EA; Mózes FE; Jayaswal ANA; Zafarmand MH; Vali Y; Lee JA; Levick CK; Young LAJ; Palaniyappan N; Liu CH; Aithal GP; Romero-Gómez M; Brosnan MJ; Tuthill TA; Anstee QM; Neubauer S; Harrison SA; Bossuyt PM; Pavlides M;
J Hepatol; 2021 Oct; 75(4):770-785. PubMed ID: 33991635
[TBL] [Abstract][Full Text] [Related]
4. Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).
Duseja A; Singh SP; De A; Madan K; Rao PN; Shukla A; Choudhuri G; Saigal S; Shalimar ; Arora A; Anand AC; Das A; Kumar A; Eapen CE; Devadas K; Shenoy KT; Panigrahi M; Wadhawan M; Rathi M; Kumar M; Choudhary NS; Saraf N; Nath P; Kar S; Alam S; Shah S; Nijhawan S; Acharya SK; Aggarwal V; Saraswat VA; Chawla YK
J Clin Exp Hepatol; 2023; 13(2):273-302. PubMed ID: 36950481
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease.
Sharpton SR; Tamaki N; Bettencourt R; Madamba E; Jung J; Liu A; Behling C; Valasek MA; Loomba R
Therap Adv Gastroenterol; 2021; 14():17562848211050436. PubMed ID: 34646360
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Furlan A; Tublin ME; Yu L; Chopra KB; Lippello A; Behari J
AJR Am J Roentgenol; 2020 Jan; 214(1):W20-W26. PubMed ID: 31714842
[No Abstract] [Full Text] [Related]
7. Diagnosis of steatohepatitis and fibrosis in biopsy-proven nonalcoholic fatty liver diseases: including two-dimension real-time shear wave elastography and noninvasive fibrotic biomarker scores.
Zhou J; Yan F; Xu J; Lu Q; Zhu X; Gao B; Zhang H; Yang R; Luo Y
Quant Imaging Med Surg; 2022 Mar; 12(3):1800-1814. PubMed ID: 35284290
[TBL] [Abstract][Full Text] [Related]
8. Advances in ultrasound elastography for nonalcoholic fatty liver disease.
Yoneda M; Honda Y; Nogami A; Imajo K; Nakajima A
J Med Ultrason (2001); 2020 Oct; 47(4):521-533. PubMed ID: 32748075
[TBL] [Abstract][Full Text] [Related]
9. Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease.
Zhang YN; Fowler KJ; Boehringer AS; Montes V; Schlein AN; Covarrubias Y; Wolfson T; Hong CW; Valasek MA; Andre MP; Loomba R; Sirlin CB
Eur Radiol; 2022 Apr; 32(4):2457-2469. PubMed ID: 34854929
[TBL] [Abstract][Full Text] [Related]
10. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.
Imajo K; Tetlow L; Dennis A; Shumbayawonda E; Mouchti S; Kendall TJ; Fryer E; Yamanaka S; Honda Y; Kessoku T; Ogawa Y; Yoneda M; Saito S; Kelly C; Kelly MD; Banerjee R; Nakajima A
World J Gastroenterol; 2021 Feb; 27(7):609-623. PubMed ID: 33642832
[TBL] [Abstract][Full Text] [Related]
11. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.
Alsaqal S; Hockings P; Ahlström H; Gummesson A; Hedström A; Hulthe J; Johansson L; Niessen HG; Schoelch C; Schultheis C; Vessby J; Wanders A; Rorsman F; Ebeling Barbier C
J Magn Reson Imaging; 2022 Aug; 56(2):368-379. PubMed ID: 34953171
[TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis assessment: MR and US elastography.
Ozturk A; Olson MC; Samir AE; Venkatesh SK
Abdom Radiol (NY); 2022 Sep; 47(9):3037-3050. PubMed ID: 34687329
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease.
Mendoza YP; Rodrigues SG; Delgado MG; Murgia G; Lange NF; Schropp J; Montani M; Dufour JF; Berzigotti A
Liver Int; 2022 Jan; 42(1):102-111. PubMed ID: 34821035
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
Younossi ZM; Loomba R; Anstee QM; Rinella ME; Bugianesi E; Marchesini G; Neuschwander-Tetri BA; Serfaty L; Negro F; Caldwell SH; Ratziu V; Corey KE; Friedman SL; Abdelmalek MF; Harrison SA; Sanyal AJ; Lavine JE; Mathurin P; Charlton MR; Goodman ZD; Chalasani NP; Kowdley KV; George J; Lindor K
Hepatology; 2018 Jul; 68(1):349-360. PubMed ID: 29222917
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Magnetic Resonance-Based Elastography and Ultrasound Shear Wave Elastography in Patients With Suspicion of Nonalcoholic Fatty Liver Disease.
Tahmasebi A; Wessner CE; Guglielmo FF; Wang S; Vu T; Liu JB; Civan J; Lyshchik A; Forsberg F; Li H; Qu E; Eisenbrey JR
Ultrasound Q; 2023 Jun; 39(2):100-108. PubMed ID: 36943721
[TBL] [Abstract][Full Text] [Related]
16. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
[TBL] [Abstract][Full Text] [Related]
17. How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography-A Review of the Literature and Proposed Multistep Approach.
Taru MG; Neamti L; Taru V; Procopciuc LM; Procopet B; Lupsor-Platon M
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832276
[TBL] [Abstract][Full Text] [Related]
18. American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
Singh S; Muir AJ; Dieterich DT; Falck-Ytter YT
Gastroenterology; 2017 May; 152(6):1544-1577. PubMed ID: 28442120
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.
Staufer K; Halilbasic E; Spindelboeck W; Eilenberg M; Prager G; Stadlbauer V; Posch A; Munda P; Marculescu R; Obermayer-Pietsch B; Stift J; Lackner C; Trauner M; Stauber RE
United European Gastroenterol J; 2019 Oct; 7(8):1113-1123. PubMed ID: 31662868
[TBL] [Abstract][Full Text] [Related]
20. Transient Versus Two-Dimensional Shear-Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD.
Cassinotto C; Boursier J; Paisant A; Guiu B; Irles-Depe M; Canivet C; Aube C; de Ledinghen V
Hepatology; 2021 Jun; 73(6):2196-2205. PubMed ID: 33236409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
